APA

Salari K., Kuppermann D., Preston M. A., Dahl D. M., Barrisford G. W., Efstathiou J. A., Blute M. L., Vesprini D., Loblaw A., Zietman A. L., Klotz L. & Feldman A. S. (20190515). Active Surveillance of Prostate Cancer is a Viable Option for Men Younger than 60 Years. : The Journal of urology.

Chicago

Salari Keyan, Kuppermann David, Preston Mark A, Dahl Douglas M, Barrisford Glen W, Efstathiou Jason A, Blute Michael L, Vesprini Danny, Loblaw Andrew, Zietman Anthony L, Klotz Laurence and Feldman Adam S. 20190515. Active Surveillance of Prostate Cancer is a Viable Option for Men Younger than 60 Years. : The Journal of urology.

Harvard

Salari K., Kuppermann D., Preston M. A., Dahl D. M., Barrisford G. W., Efstathiou J. A., Blute M. L., Vesprini D., Loblaw A., Zietman A. L., Klotz L. and Feldman A. S. (20190515). Active Surveillance of Prostate Cancer is a Viable Option for Men Younger than 60 Years. : The Journal of urology.

MLA

Salari Keyan, Kuppermann David, Preston Mark A, Dahl Douglas M, Barrisford Glen W, Efstathiou Jason A, Blute Michael L, Vesprini Danny, Loblaw Andrew, Zietman Anthony L, Klotz Laurence and Feldman Adam S. Active Surveillance of Prostate Cancer is a Viable Option for Men Younger than 60 Years. : The Journal of urology. 20190515.